Duncan Williams Asset Management’s Pfizer PFE Stock Holding History

Duncan Williams Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Hold	10,448	–	–	0.06%	148
2026 Q1	$293K	Sell	10,448 -4,084	-28%	-$109K	0.08%	123
2025 Q4	$389K	Sell	14,532 -154	-1%	-$3.88K	0.1%	119
2025 Q3	$374K	Sell	14,686 -802	-5%	-$19.8K	0.11%	118
2025 Q2	$375K	Buy	15,488 +314	+2%	+$7.32K	0.12%	103
2025 Q1	$384K	Sell	15,174 -449	-3%	-$11.7K	0.14%	97
2024 Q4	$414K	Buy	15,623 +4,416	+39%	+$120K	0.16%	92
2024 Q3	$324K	Buy	+11,207	New	+$327K	0.18%	93

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Duncan Williams Asset Management's PFE Position: Q2 2026 in Review

Duncan Williams Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 10,448 shares worth $252K. The position accounts for 0.06% of the portfolio, ranked #148.

Duncan Williams Asset Management first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $414K in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Duncan Williams Asset Management held 10,448 shares of Pfizer worth $252K as of Q2 2026.
Duncan Williams Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.06% of Duncan Williams Asset Management's portfolio in Q2 2026, its #148 holding.
Duncan Williams Asset Management first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
Duncan Williams Asset Management's Pfizer position peaked at $414K in Q4 2024.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.